Meet
Eleanor Fitall

Eleanor Fitall provides research and analytical support to Avalere's Evidence Translation and Implementation practice, primarily focusing on data-driven quality improvement efforts in both the public and private sectors.

Prior to joining Avalere, Eleanor interned for Galileo Analytics, where she assisted in the analysis of pharmaceutical pipeline development by tracking and conducting studies on upcoming pharmaceutical research. Additionally, while serving as a research and marketing assistant for the chief operating officer, she conducted domestic and international market research and assisted in the development of product launch plans.

Eleanor has a MPH from The Johns Hopkins University with a concentration in quality, patient safety, and outcomes research and a dual BA in international studies and sociology from Emory University.

Authored Content


To better understand key motivations and barriers to using PROs in clinical care, Avalere conducted a literature review, identified existing PRO-PMs in use by payers through our proprietary quality measures database, and conducted interviews with early adopters of PROs. In this paper, we provide our findings and recommendations for next steps.

In June 2016, Avalere in collaboration with the American Society of Clinical Oncology, Cancer Support Community, Community Oncology Alliance, and Patient Advocate Foundation, and with support from Bristol-Myers Squibb, brought together a variety of healthcare stakeholders in a national Dialogue to discuss challenges and opportunities surrounding the advancement of quality in cancer care.